CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 144 Insider Sale of Securities
- 4 Open-market sale CLO & Secretary sold 500 shares at $114.54 ($57,271)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 188 shares (to pay taxes)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Open-market sale CLO & Secretary sold 1,000 shares at $104.00 ($104,000)
- 4 Option exercise Director acquired 2,406 shares (option exercise)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Executive Officer bought 9,510 shares at an average $105.20 ($1,000,456)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at an average $104.06 ($156,090)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
Page 9 of 115 · 2,300 filings